Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus.
Complementary DNA clones corresponding to one of the putative structural regions of the hepatitis C virus (HCV) genome were obtained from sera of non-A non-B hepatitis patients. The putative envelope gene was expressed by using a recombinant vaccinia virus carrying this region of the HCV genome. In cells infected with the recombinant vaccinia virus, a glycosylated protein with an M(r) of about 35K (gp35) was specifically detected by convalescent sera from hepatitis C patients. The sera from rabbits immunized with this recombinant vaccinia virus reacted to the gp35 produced in insect cells and also to gp35 which was translated in vitro in the glycosylated and processed form. The gp35 was used to detect antibodies in sera of only 7 to 23% of HCV patients at various stages of HCV disease. These results suggest that the gp35 of HCV may not have high antigenicity in humans.
Kohara
M
M
Fundamental Research Laboratory, Tonen Co. Nishi-Tsurugaoka, Saitama, Japan.
Tsukiyama-Kohara
K
K
Maki
N
N
Asano
K
K
Yamaguchi
K
K
Miki
K
K
Tanaka
S
S
Hattori
N
N
Matsuura
Y
Y
Saito
I
I
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis* / Q000276:immunology; D016367:Baculoviridae / Q000235:genetics; D001483:Base Sequence; D003001:Cloning, Molecular; D004277:DNA, Single-Stranded / Q000235:genetics; D006023:Glycoproteins / Q000096:biosynthesis* / Q000235:genetics* / Q000276:immunology; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008969:Molecular Sequence Data; D011994:Recombinant Proteins / Q000096:biosynthesis; D014616:Vaccinia virus / Q000235:genetics; D014764:Viral Proteins / Q000096:biosynthesis* / Q000235:genetics* / Q000276:immunology
D000914:Antibodies, Viral; D004277:DNA, Single-Stranded; D006023:Glycoproteins; D011994:Recombinant Proteins; D014764:Viral Proteins; C077083:glycoprotein 35, Hepatitis C virus